Outset Medical
Outset Medical is a NASDAQ-listed medical technology company that sells the Tablo Hemodialysis System to U.S. hospitals, health systems, skilled nursing facilities, and home dialysis patients, combining integrated water purification, sensor-based automation, and cloud-connected EMR integration in a single device.
- Company typePublic
- Founded2003
- HeadquartersSan Jose, United States
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Outset Medical does
Outset Medical is a publicly traded medical technology company (NASDAQ: OM) that designs and sells the Tablo Hemodialysis System, an integrated dialysis platform targeting acute and home dialysis settings for U.S. hospitals, health systems, skilled nursing facilities, and end-stage kidney disease patients. Tablo combines on-site water purification, on-demand dialysate generation, a touchscreen-guided user interface, sensor-based automation, a single-use pre-assembled cartridge, and two-way cloud connectivity in a single enterprise device, covering roughly 95 percent of hospital dialysis treatments including ICU, PIRRT, and SLED without requiring a dedicated water room. The next-generation platform received FDA 510(k) clearance incorporating the agency's June 2025 cybersecurity guidance and is the first hemodialysis system to do so.
The company's revenue model combines hardware sales of the Tablo device with recurring service and support contracts, recurring single-use cartridge and accessory consumables, and ancillary services such as clinical training, the Bridge Program for transitional staffing during insourcing, and the Destination Home home-program launch offering. Go-to-market is a direct enterprise field-sales motion targeting hospital administrators, nephrologists, and nursing leadership, supplemented by a patient-facing channel for home hemodialysis and a partnership with US Renal Care. Outset serves nearly 1,000 U.S. hospitals and health systems, including all eight of the largest U.S. national health systems, and reported $119.5 million in full-year 2025 revenue with non-GAAP gross margin of 39.6 percent and operating cash burn reduced to $46 million from $116 million in 2024. The company is headquartered in San Jose, California, manufactures in North America, and employs 251 to 500 people.
Outset Medical firmographics
Firmographics- Name
- Outset Medical
- Legal name
- Outset Medical, Inc.
- Website
- https://outsetmedical.com
- Company type
- Public
- Founded year
- 2003
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Outset Medical is a NASDAQ-listed medical technology company that sells the Tablo Hemodialysis System to U.S. hospitals, health systems, skilled nursing facilities, and home dialysis patients, combining integrated water purification, sensor-based automation, and cloud-connected EMR integration in a single device.
- Ownership category
- akta.pro rank
Outset Medical industry classification
Industry- Product category
- Hemodialysis Equipment
- NAICS
- Kidney Dialysis Centers (621492)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodialysis Machines & Systems (HLAHAKAA)
- akta.pro secondary industries
- Home Dialysis Equipment & Remote Monitoring (HLAHAKAG), Dialysis Water Treatment & Dialysate Delivery Systems (HLAHAKAD)
Keywords
Where Outset Medical is headquartered
LocationHeadquarters
- HQ city
- San Jose
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Outset Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Tablo Hemodialysis System Hardware Sales: Outset Medical generates revenue primarily from selling the Tablo dialysis system hardware to hospitals, healthcare systems, skilled nursing facilities, and home dialysis programs. The system is sold as a capital device with various purchase and service agreement options.
- Service and Support Contracts: Annual service agreements covering technical support, software updates, preventive maintenance, and field service. Agreements may include planned maintenance, on-site support, phone support, and biomed training through the Partnership program.
- Consumables and Accessories: Revenue from single-use Tablo cartridges and accessories used with each treatment. The cartridge is pre-assembled and replaced per treatment.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Outset Medical product offering
Product offeringCore offering
Outset Medical designs, manufactures, and sells the Tablo Hemodialysis System — a single, all-in-one console that integrates water purification, on-demand dialysate generation, and treatment delivery with a guided touchscreen interface and cloud connectivity. The platform is deployed in acute care hospitals, skilled nursing facilities, and patient homes for both in-center and home hemodialysis, supported by recurring single-use Tablo cartridge consumables and data/subscription services.
Product overview
Outset Medical offers a unified product ecosystem centered on the Tablo Hemodialysis System, a first-of-its-kind dialysis device covering 95% of acute and home dialysis treatments. The ecosystem includes TabloCart (mobile accessory), TabloHub (provider data/portal platform), and MyTablo (patient portal). EMR Connect enables integration with major EMR platforms like Epic, Cerner/Oracle Health, Meditech, and Gaia via HL7v2 or API/JSON. The company also provides comprehensive support services including Clinical Training, Technical Service, Bridge Program (temporary staffing), Destination Home (home program launch), Discover Dialysis (education), and Vascular Access Program.
Differentiator
Problem solved
Functional benefit
Brands
- Tablo: Tablo Hemodialysis System - a first-of-its-kind dialysis system designed for acute and home dialysis care.
- TabloHub
- MyTablo
- TabloCart
- Outset Connect
- EMR Connect
Products and services
- Tablo Hemodialysis System All-in-one hemodialysis machine with integrated water purification, on-demand dialysate generation, touchscreen-guided operation, and cloud connectivity, used in acute care hospitals, skilled nursing facilities, and home hemodialysis for end-stage renal disease patients.
- Tablo Cartridge Single-use disposable cartridge consumable used with the Tablo Hemodialysis System for each dialysis treatment, generating recurring revenue per treatment.
- TabloCart Mobile cart accessory that allows the Tablo Hemodialysis System console to be transported easily within a hospital, clinic, or care facility.
- TabloHub Cloud-based data and clinical workflow platform that aggregates treatment data from Tablo consoles for monitoring, analytics, and operational reporting by healthcare providers.
- MyTablo Patient-facing mobile application for individuals performing home hemodialysis with Tablo, supporting treatment setup, progress tracking, education, and communication with care teams.
- EMR Connect Integration solution that connects the Tablo system and TabloHub to hospital electronic medical record (EMR) systems, automating documentation and clinical data exchange.
- Tablo Service and Support Plans Post-sale service, maintenance, training, and technical support agreements for healthcare providers operating the Tablo Hemodialysis System.
Quantifiable outcome
- 94% reduction in serious cardiac or respiratory events over 5 years at AdventHealth
- +9 more outcomes
Companies that use Outset Medical
Customer profileNamed customers9 records
Segments3 records
Ideal customer profiles3 records
Outset Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
Feature8 records
Outset Medical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- US Renal CarecoreUS Renal Care partnered with Outset Medical to offer patients accessible and easy-to-use home dialysis tools through the Tablo system. The partnership was specifically mentioned as helping fuel home dialysis participation growth and expanding patient access to home hemodialysis options.
Scale indicators14 records
Recent moves6 records
Expansion highlights5 records
Outset Medical competitors and assessment
Company assessmentBroad incumbents
- Fresenius Medical Care: World's largest dialysis products and services company, manufacturing hemodialysis machines (e.g., 2008T) and operating the largest U.S. dialysis clinic network. Competes head-on with Outset across acute care, home dialysis, and consumables, but with a vastly broader product portfolio and entrenched service relationships.
- DaVita: Leading U.S. dialysis services provider that also supplies equipment and home dialysis programs. While primarily a services company, DaVita competes with Outset's hospital insourcing narrative because hospitals insource to reduce dependence on DaVita/Fresenius outsource contracts.
- Baxter International: Major medical device manufacturer offering hemodialysis systems (e.g., AK 98) and PD solutions used in hospitals and clinics. Baxter is a direct equipment competitor to Tablo in acute and chronic hemodialysis settings, with established hospital procurement relationships.
- B. Braun Avitum: Dialysis products division of B. Braun manufacturing hemodialysis machines and disposables. Competes with Tablo in hospital and clinic settings across Europe and the U.S., with broader medical device portfolio.
Direct peers
- Quanta Dialysis Technologies: UK-based developer of the SC+ hemodialysis system, a compact, easy-to-use device designed for both clinical and home use—directly mirroring Tablo's positioning. Competes head-to-head with Outset in portable/streamlined hemodialysis.
- NxStage Medical (Fresenius): Pioneer in home hemodialysis with the System One, now owned by Fresenius. Targets the same home and acute dialysis markets as Outset, with comparable positioning around portability and patient independence.
Regional players
- U.S. Renal Care: U.S. dialysis services provider and Outset's home dialysis partner. While not a direct equipment competitor, it is a relevant comparable because it operates the home modality infrastructure through which Tablo reaches patients.
- Dialyze Direct: Provider of on-site dialysis in skilled nursing facilities (SNFs). Competes with Outset's SNF channel and shares the SNF-dialysis thesis, though as a services operator rather than equipment maker.
- Innovative Renal Care (formerly American Renal Associates): U.S. dialysis services provider offering in-center and home dialysis. Relevant comparable as a customer/channel partner for Tablo-equivalent home dialysis equipment and as a service-line competitor to hospital insourcing.
Others
- Medtronic: Large diversified medical device company with adjacent hospital capital equipment expertise and digital health integrations (analogous to Tablo's EMR Connect strategy). Relevant as a benchmark for medtech scale and as a potential strategic acquirer of connected-device franchises.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Outset Medical social profiles
Digital presenceOutset Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Outset Medical leadership team
Management profileNumber of profiles
Profiles4 records
Outset Medical funding detail
Funding detailFunding overview
Funding rounds14 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Outset Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Outset Medical
What does Outset Medical do?
Outset Medical designs, manufactures, and sells the Tablo Hemodialysis System — a single, all-in-one console that integrates water purification, on-demand dialysate generation, and treatment delivery with a guided touchscreen interface and cloud connectivity. The platform is deployed in acute care hospitals, skilled nursing facilities, and patient homes for both in-center and home hemodialysis, supported by recurring single-use Tablo cartridge consumables and data/subscription services.
Is Outset Medical a public or private company?
Outset Medical is a public company. It is classified as public and is currently operating.
When was Outset Medical founded?
Outset Medical was founded in 2003. It employs 251 to 500 people.
Where is Outset Medical based?
Outset Medical is headquartered in San Jose, United States, in the North America region.
How does Outset Medical make money?
Three revenue lines are on record. Tablo Hemodialysis System Hardware Sales are the primary driver. The others are service and Support Contracts and consumables and Accessories.
Who are Outset Medical's main competitors?
Broad incumbents on record are Fresenius Medical Care, DaVita, Baxter International and B. Braun Avitum. Direct peers are Quanta Dialysis Technologies and NxStage Medical (Fresenius). Regional players are U.S. Renal Care, Dialyze Direct and Innovative Renal Care (formerly American Renal Associates). Medtronic is listed as an others.
Does Outset Medical have an API?
Yes. Tablo's EMR Connect supports HL7v2 and API/JSON communication options for secure, cloud-based two-way data transfer. The system transmits 70+ treatment fields, real-time updates, and event-based alerts from Tablo to compatible EMR platforms. This enables automated patient charting and documentation workflows.
What industry is Outset Medical in?
Outset Medical's product category is Hemodialysis Equipment. Its primary akta.pro industry code is HLAHAKAA, Hemodialysis Machines & Systems, with a secondary code of HLAHAKAG, Home Dialysis Equipment & Remote Monitoring. Its NAICS code is 621492 and its SIC code is 3841.